These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15887972)

  • 1. A new structural motif for mu-opioid antagonists.
    Van den Eynde I; Laus G; Schiller PW; Kosson P; Chung NN; Lipkowski AW; Tourwé D
    J Med Chem; 2005 May; 48(10):3644-8. PubMed ID: 15887972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
    Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
    J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
    Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
    Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.
    Balboni G; Onnis V; Congiu C; Zotti M; Sasaki Y; Ambo A; Bryant SD; Jinsmaa Y; Lazarus LH; Trapella C; Salvadori S
    J Med Chem; 2006 Sep; 49(18):5610-7. PubMed ID: 16942034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice.
    Iwata H; Tsuchiya S; Nakamura T; Yano S
    Eur J Pharmacol; 2007 Nov; 574(1):66-70. PubMed ID: 17632101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Jinsmaa Y; Bryant SD; Lazarus LH
    J Med Chem; 2002 Dec; 45(25):5556-63. PubMed ID: 12459023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,6-Dimethyltyrosine analogues of a stereodiversified ligand library: highly potent, selective, non-peptidic mu opioid receptor agonists.
    Harrison BA; Pasternak GW; Verdine GL
    J Med Chem; 2003 Feb; 46(5):677-80. PubMed ID: 12593647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans.
    Czakó B; Marton J; Berényi S; Gach K; Fichna J; Storr M; Tóth G; Sipos A; Janecka A
    Bioorg Med Chem; 2010 May; 18(10):3535-42. PubMed ID: 20413312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands.
    Ballet S; Salvadori S; Trapella C; Bryant SD; Jinsmaa Y; Lazarus LH; Negri L; Giannini E; Lattanzi R; Tourwé D; Balboni G
    J Med Chem; 2006 Jun; 49(13):3990-3. PubMed ID: 16789756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dmt and opioid peptides: a potent alliance.
    Bryant SD; Jinsmaa Y; Salvadori S; Okada Y; Lazarus LH
    Biopolymers; 2003; 71(2):86-102. PubMed ID: 12767112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus.
    Ballet S; De Wachter R; Van Rompaey K; Tömböly C; Feytens D; Töth G; Quartara L; Cucchi P; Meini S; Tourwé D
    J Pept Sci; 2007 Mar; 13(3):164-70. PubMed ID: 17266049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.